Factor 7 deficiency is a rare inherited bleeding disorder caused by a lack of coagulation factor VII, which plays a key role in the process of clot formation and bleeding control. The condition can manifest itself as discrete, often minor but repeated hemorrhages, or as more serious bleeding. People with factor 7 deficiency may experience episodes of nosebleeds and gum bleeding that may be difficult to control. Advanced cases can lead to serious complications, such as severe bleeding, requiring immediate medical attention and intervention. Clarification of the diagnosis involves the use of a variety of coagulation laboratory tests, including the activated partial thromboplastin time (aPTT) and prothrombin time (PT).
History of the disease and interesting historical facts
The first description of factor 7 deficiency was made in 1952, when a group of researchers led by Professor A. L. Kozlov discovered anomalies in the hemostatic system in several members of one family. Later, in 1983, molecular biology confirmed that factor 7 deficiency is an inherited disorder associated with mutations in the F7 gene responsible for the synthesis of factor 7. Interestingly, in some regions of the world, there are family clans with a high predisposition to this disease, which allowed for in-depth genetic studies and a better understanding of its pathophysiology. Since then, the study of factor 7 deficiency has expanded significantly, thanks to the assistance of genetic diagnostics and new therapeutic approaches.
Epidemiology
Factor 7 deficiency is one of the rarest types of hemophilia. The prevalence of this condition varies by population and geographic region. The incidence of factor 7 deficiency is estimated to be approximately 1 in 1 million people. Unlike more common forms of hemophilia, such as hemophilia A and B, cases of factor 7 deficiency are rare and often go undiagnosed. Of the cases identified, almost 70% are hereditary, but acquired disease is also possible, usually associated with liver failure.
Genetic predisposition to this disease
Factor 7 deficiency is a hereditary disorder that is transmitted in an autosomal recessive manner. The main gene involved in this disorder is the F7 gene, located on chromosome 13. Many mutations in this gene have been identified to date, with point mutations and deletions being the most studied. The hereditary form typically manifests itself early in life, and symptoms may begin in the first months of life or in childhood. It is assumed that due to the low frequency of observation, a comprehensive study of the genetics of this disorder requires a large-scale study and registration of cases to clarify the impact of various mutations on clinical manifestations.
Risk factors for the development of this disease
The main risk factor for developing factor 7 deficiency is a family history of the disease, as the condition is hereditary. Some factors that contribute to the development of the disease include:
- Heredity: sick relatives, transmission by autosomal recessive type.
- Lifestyle: lack of physical activity or occupational factors associated with frequent injuries.
- Concomitant liver diseases that may lead to coagulation factor deficiency.
- Certain medications may decrease the level of factor 7 in the blood.
- Environmental influences and potential contact allergens that may influence the systemic immune response.
Diagnosis of this disease
Diagnosis of factor 7 deficiency requires a balanced approach and preliminary clinical analysis. The main symptoms of the disease may include:
- Frequent nosebleeds.
- Bleeding gums.
- Petechiae and hemorrhagic rashes on the skin.
- Prolonged bleeding after injury or surgery.
Laboratory tests include:
- A complete blood count to determine hemoglobin and platelet levels.
- Coagulation tests such as aPTT and PT, which detect changes
- Specific tests for factor 7 levels in plasma.
Radiological examinations may be necessary in cases where possible internal bleeding is suspected. It is important to make a differential diagnosis with other conditions, such as hemophilia A and B, as well as with some acquired hemostatic disorders.
Treatment
General treatment of factor 7 deficiency involves ensuring the prevention and control of bleeding. The main focus is on eliminating factors that may increase the risk of bleeding. Pharmacological treatment is based on the administration of factor 7 concentrates:
- Factor 7 concentrates (recombinant or plasma-derived).
- Coagulation activating factors such as desmopressin for the treatment of the acquired form.
In some cases, surgery may be required for hemorrhages that do not respond to conservative therapy. Other treatments may include:
- Irradiation and prevention of infection caused by bleeding.
- Prevention and control of concomitant diseases affecting factor 7 levels.
List of medications used to treat this disease
- Recombinant factor 7
- Plasma-derived factor 7 preparations
- Desmopressin
- Factors that activate coagulation
- Painkillers and anti-inflammatory drugs to reduce complement response
Disease monitoring
Disease monitoring includes control stages that allow assessing the effectiveness of treatment and the general condition of the patient. The prognosis depends on the severity of the disease and the effectiveness of therapy. Complications may include:
- Severe bleeding due to trauma or surgery.
- Development of intraparenchymal or intracranial hemorrhages.
- Potential thrombotic events due to high levels of factor 7.
Age-related features of the disease
Factor 7 deficiency can manifest itself at different stages of life, but clinical manifestations often become noticeable in childhood. Children may have a milder course of the disease, while adults may experience more severe symptoms. In older people, the risk of complications may increase due to underlying diseases and conditions such as hypertension and atherosclerosis.
Questions and Answers
- Is it possible to live with factor 7 deficiency? Yes, many patients begin to live with this condition, following the doctor's recommendations and taking the necessary medications.
- How often should you test your factor 7 levels? Regular testing of factor 7 levels varies by individual, but is recommended every 3-6 months.
- What lifestyle should you lead if you have factor 7 deficiency? Patients are advised to avoid injuries and maintain an active lifestyle, but without excessive stress.
- Can factor 7 deficiency go away with age? In most cases, the disease persists, but its manifestations may change with age, especially in connection with other conditions.
- What is the main health risk of factor 7 deficiency? The main risk is possible bleeding, which can lead to serious complications, so it is important to take precautions.
Advice from Dr. Oleg Korzhikov:
"It is important to understand that monitoring the level of factor 7 in the blood, regular visits to the doctor and following all recommendations for therapy can significantly increase the quality of life. Do not neglect preventive examinations and be attentive to any changes in your condition. If you have close relatives with factor 7 deficiency, try to undergo genetic counseling. This will allow you and your children to better understand your risks and prevent possible complications."
